Huang, J; Beyer, C; Palumbo-Zerr, K; Zhang, Y; Ramming, A; Distler, A; Gelse, K; Distler, O; Schett, G; Wollin, L; Distler, J H W (2016). Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis. Annals of the Rheumatic Diseases, 75(5):883-890.
Wohlfahrt, T; Usherenko, S; Englbrecht, M; Dees, C; Weber, S; Beyer, C; Gelse, K; Distler, O; Schett, G; Distler, J H W; Ramming, A (2016). Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Annals of the Rheumatic Diseases, 75(3):623-626.
Reich, N; Beyer, C; Gelse, K; Akhmetshina, A; Dees, C; Zwerina, J; Schett, G; Distler, O; Distler, J H W (2011). Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts. Journal of Cellular and Molecular Medicine, 15(4):756-762.